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Aim and scope: We conducted this study to estimate the incidence of hyperbilirubinemia 
in a small neonatal care unit in Catania, Italy, and to determine the underlying causes, which 
would be of value in identifying and implementing strategies to prevent morbidity from this 
condition.
Background: Management of hyperbilirubinemia remains a challenge for neonatal medicine 
because of the risk for serious neurological complications related to the toxicity of bilirubin.
Methods: From January 2006 to January 2007, we screened 525 newborns born at the Neonatal 
Care Unit of Valsalva Hospital in Catania, Italy. Infants aged 3–5 days and with unconjugated 
hyperbilirubinemia were included for assessment if they had a peak serum total bilirubin level 
exceeding 6 mg/dl (102 μmol/L). Sex, birth weight, gestational age, breast feeding, type of 
birth, presence of facial bruising (including cephalohematoma) and ABO group were noted. 
Patients with Toxoplasma or Cytomegalovirus infection, hepatic insufﬁ  ciency, or suspected 
drug-induced hyperbilirubinemia were excluded from more detailed analysis.
Results: Our year-long nursery sample examined otherwise healthy-appearing term infants for 
the prevalence of hyperbilirubinemia (deﬁ  ned as bilirubin levels exceeding 6 mg/dL [11mol/L]). 
We found hyperbilirubinemia in 19% (100/525). Among the patients with hyperbilirubinemia, 
almost all (99%) had peak levels of bilirubin 20 mg/dL, levels which are generally considered 
to be potentially neurotoxic.
Conclusions: In our clinic experience, hyperbilirubinemia was generally a serious medical 
issue and one whose etiology can usually be well deﬁ  ned.
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Introduction
Severe hyperbilirubinemia continues to be the most common cause of neonatal read-
mission for hospitals in North America.1–5 This pattern continues despite attempts to 
identify newborns at risk of clinically important hyperbilirubinemia before they are 
discharged from hospital.6–9 Long-term results of severe hyperbilirubinemia, including 
bilirubin encephalopathy and kernicterus, were thought to be rare since the advent of 
exchange transfusion, maternal Rh immunoglobulin prophylaxis, and phototherapy.10–12 
However, cases of kernicterus have been reported recently in healthy near-term and 
term infants without evidence of hemolytic disease or other risk factors.13,14
We begin our study of this problem with a survey of a single clinic experience over 
a year with respective to severity and probable causes of hyperbilirubinemia.
Background
Management of hyperbilirubinemia remains a challenge for neonatal medicine 
because of the risk for serious neurological complications related to the toxicity of 
bilirubin. The neonatal hyperbilirubinemia practice guidelines published in 2004 by 
the American Academy of Pediatrics (AAP) expresses the pediatric community’s 
concern regarding bilirubin-induced neurological pathology. Risk factors recognized Therapeutics and Clinical Risk Management 2009:5 248
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to be associated with severe hyperbilirubinemia in newborns 
have included jaundice in the ﬁ  rst 24 hours of life, jaundice 
noted before discharge from hospital, a sibling who had 
jaundice treated with phototherapy, near-term gestational age 
of  35–36 weeks, and the presence of infant with bruising or 
cephalohematoma.
Materials and methods
From January 2006 to January 2007, we screened 525 newborns 
born at the Neonatal Care Unit of Valsalva Hospital in Catania, 
Italy. Infants aged 3–5 days and with unconjugated hyper-
bilirubinemia were included for assessment if they had a peak 
serum total bilirubin level exceeding 6 mg/dl (102 μmol/L). 
Sex, birth weight, gestational age, breast feeding, type of birth, 
presence of facial bruising (including cephalohematoma), 
and ABO group were noted. Patients with Toxoplasma or 
Cytomegalovirus infection, hepatic insufﬁ  ciency, or suspected 
drug-induced hyperbilirubinemia were excluded from more 
detailed analysis.
We focused on healthy term infants without risk factors. 
Infants who had known Rh iso-immunization were excluded 
since antenatal and postnatal strategies already exist to 
prevent the occurrence of severe neonatal hyperbilirubinemia 
from this cause. Infants who were born at less than 36 weeks’ 
gestational age were also excluded as well as newborn 
with severe facial bruising or cephalohematoma from more 
detailed analysis.
Data were summarized using descriptive statistics. 
Continuous variables were analyzed using the independent 
Student’s t-test and Fisher’s exact test. A chi square test was used 
to test associations between all other categorical variables.
Results
We found 100 children with unconjugated hyperbilirubinemia. 
Causes identiﬁ  ed by laboratory investigations include Rh 
and ABO incompatibility, as well as glucose-6-phosphate 
dehydrogenase (G6PD) deﬁ  ciency. We found potentially 
neurotoxic levels of hyperbilirubinema in only one case, 
with value of peak bilirubin of 20 mg/dL (342 mmol/L), 
treated with phototherapy. The other 99 cases had milder 
hyperbilirubinemia and did not receive any treatment.
In our series, we found breastfeeding in 65 cases, cesarean 
section in 61, and mild facial bruising in 16. Medicaments 
during the pregnancy were used in 39 cases and post-pregnancy 
in 35 (Table 1). A single case showed evidence of liver 
disease (Gilbert disease). Cytomegalovirus and toxoplasmosis 
infection were found in 2% and 6% of the cases, respectively 
(Table 1). Maternal microcytosis was found in two cases.
We also evaluated the ABO group in the mothers and 
in the newborns (Table 2). No signiﬁ  cant differences were 
found in the examined group. No other risk factors were 
found in those patients.
We tried to analyze the characteristics of neonatal 
jaundice. We took in consideration over 525 children, 
100 infants with a value of bilirubin level of more than 
6 mg/dl (102 μmol/L) (Table 3).
Discussion
Hyperbilirubinemia is felt to be a benign condition for 
infants born at term or near-term gestation. In around 5% 
of healthy term infants, however, serum bilirubin values 
exceed 17 mg/dL (291 mmol/L), a value which the AAP 
deems signiﬁ  cant.4 Levels exceeding 20 mg/dL (342 mmol/L) 
occur in 1.2% of healthy newborn infants.11 The vast majority 
of infants with serum bilirubin values of 20 mg/dL remain 
well; mostly need minimal care other the occasional use of 
phototherapy and careful monitoring of serum levels. Before 
1990, kernicterus in the previously healthy-term infant was 
extraordinarily rare and for most pediatricians, it was a 
Table 1 Pregnancy factors
Yes No Total
Breastfeeding 65 35 100
Cesarian section 61 39 100
Spontaneous delivery 39 61 100
Bruising face 16 84 100
Drugs in pregnancy 39 61 100
Drugs after pregnancy 35 65 100
Liver disease 1 99 100
Cytomegalovirus in pregnancy 2 98 100
Microcytemic mother 2 98 100
Toxoplasmosis in pregnancy 6 94 100
Table 2 Blood groups
Blood group Maternal group Children group
0− 56
0+ 52 48
A− 22
A+ 17 29
B− 61
B+ 16 13
AB+ 21
AB− 00
Total 100 100Therapeutics and Clinical Risk Management 2009:5 249
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disease they were unlikely to see in their practice lifetimes. 
Since 1990, there has been an increase in the number of 
reported cases of kernicterus in the United States.7 Thirty-one 
cases have been reported in term infants who were well at 
the time of hospital discharge, and several additional cases 
have occurred in near-term infants. Although it is unknown 
whether there is an actual increase in the incidence of 
kernicterus in the United States or simply better detection, 
reported cases are thought to be attributable to a variety of 
events including: shortened hospital stays with inconsistent 
follow-up beyond discharge; an increase in the frequency 
of breastfeeding; and a lack of concern about high bilirubin 
levels among pediatric care providers.
Although the relationship between hyperbilirubinemia and 
brain injury in healthy term infants has been recently ques-
tioned,17 in a reevaluation of the data from the Collaborative 
Perinatal Project, Newman and Klebanoff10 could not dem-
onstrate a relationship between bilirubin levels 26 mg/dL 
(342 uM/L) and an abnormal neurologic examination.
Breastfeeding is still debated as probably an important 
variable in these patients. In the present series, almost 65% 
of hyperbilirubemic patients were breastfed, as it has been for 
the other cases of kernicterus reported in the literature.3,7,17 In 
our series, no signiﬁ  cance statistical difference in bilirubin 
levels were found according to whether or not the infant 
was breastfed.
In a case-controlled study Maisels8 found that hyper-
bilirubinemia was the major reason for hospital readmission 
during the ﬁ  rst two weeks of life. Moreover, the majority of 
the jaundiced infants in their study were breastfed and had 
a greater mean weight loss since birth than nonjaundiced 
controls, suggesting that even mild degrees of dehydration 
in conjunction with breastfeeding impacts on the severity of 
hyperbilirubinemia.
Our series comes from a small center in Catania, Italy. 
Catania is one of the sunniest spots on Earth, with approxi-
mately 225 sunny days per year (which does not include 
partly cloudy days). It is possible that this plays some role 
in the relatively low incidence of hyperbilirubinemia in 
our studies as compared to previous studies. Furthermore 
future studies should investigate the presence of individual 
susceptibility, environmental factors, especially environmental 
climate (daylight), and genetic factors to explain the different 
incidences of the disease, and the frequency of such ﬁ  ndings 
in infants with moderate degrees of hyperbilirubinemia and 
possible modes of prevention and new therapeutic strategies.
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